Sulfinpyrazone
Back to searchMolecule Structure
Scientific Name
Sulfinpyrazone
Description of the Drug
Sulfinpyrazone is a platelet inhibitory and uricosuric agent used to inhibit thrombotic and embolic processes and to manage the chronic phases of gout .
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01138
http://www.drugbank.ca/drugs/DB01138
Brand Name(s)
Anturan, Anturane, Sulfinpyrazone
Company Owner(s)
Watson Laboratories Inc, Par Pharmaceutical Inc, Vangard Laboratories Inc Div Midway Medical Co, Ivax Pharmaceuticals Inc, Barr Laboratories Inc, Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Solute carrier family 22 member 12 | SINGLE PROTEIN | INHIBITOR | CHEMBL6120 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL34421 |
PharmGKB | PA451550 |
Human Metabolome Database | HMDB0015269 |
DrugBank | DB01138 |
PubChem: Thomson Pharma | 14879380 |
PubChem | 5342 |
Mcule | MCULE-8521771467 |
LINCS | LSM-1491 |
Nikkaji | J1.384F |
BindingDB | 50237626 |
EPA CompTox Dashboard | DTXSID0023618 |
DrugCentral | 2528 |
Brenda | 8421 |
ChemicalBook | CB2122351 |
Guide to Pharmacology | 5826 |
rxnorm | SULFINPYRAZONE |
KEGG Ligand | C07317 |
ChEBI | 9342 |